title: The dysfunction of inhibition control in pituitary patients: evidence from the Go/Nogo event-related potential study.
abstract: Pituitary tumor is an intracranial tumor; because of the development of neuroimaging technology in recent years, morbidity is likely to increase. Evidence showed impaired cognitive ability of patients with pituitary adenoma. There is evidence that neurobehavioral disorders are common in pituitary adenoma patients. This disorder is because of the cognitive and emotional function of the important functional areas of the brain oppressed and hormone imbalance. Individuals' mental activity is controlled by the brain and the abnormal mental activity is caused by both the structural abnormalities of the brain and neurochemical dysfunction. Event-related potentials have been used widely in the early assessment of cognitive functions associated with disease, taking advantage of the high temporal resolution, and then analyzing the characteristics of emotional competence from the perspective of cognitive processing. A visual Go/Nogo task was used. A larger Nogo-N2 and Nogo-P3 was found in the control group compared with the pituitary group. This reflects the nonphysiological process of conflict monitoring and inhibitory control in pituitary patients. The results also showed that the difference waves between Go and Nogo conditions (N2d and P3d) over the frontal electrode sites were more robust and earlier in the control group compared with the pituitary group, which reflects frontal dysfunction in the pituitary group. These data suggest reduced earlier and later stages of inhibitory processes in pituitary individuals, implicating the dysfunction of conflict detection and inhibitory control.
authors.affiliation: aGraduate School of Southern Medical University, Guangzhou bDepartment of Neurosurgery, Wuhan General Hospital, Wuhan cDepartment of Neurosurgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
authors.forename: Chenglong
authors.initials: C
authors.lastname: Cao
authors.forename: Jian
authors.initials: J
authors.lastname: Song
authors.forename: Shun
authors.initials: S
authors.lastname: Yao
authors.forename: Yan
authors.initials: Y
authors.lastname: Yan
authors.forename: Shun
authors.initials: S
authors.lastname: Li
authors.forename: Guibao
authors.initials: G
authors.lastname: Peng
authors.forename: Pan
authors.initials: P
authors.lastname: Ma
authors.forename: Hao
authors.initials: H
authors.lastname: Du
authors.forename: Cheng
authors.initials: C
authors.lastname: Huang
authors.forename: Huichao
authors.initials: H
authors.lastname: Ding
authors.forename: Yuanzhi
authors.initials: Y
authors.lastname: He
authors.forename: Ronghui
authors.initials: R
authors.lastname: Sun
authors.forename: Guozheng
authors.initials: G
authors.lastname: Xu
mesh_terms: D000236:Adenoma / Q000150:complications*; D000328:Adult; D001931:Brain Mapping; D003072:Cognition Disorders / Q000209:etiology*; D003657:Decision Making / Q000502:physiology*; D004569:Electroencephalography; D005071:Evoked Potentials / Q000502:physiology*; D005260:Female; D006801:Humans; D007266:Inhibition, Psychological; D008297:Male; D009483:Neuropsychological Tests; D010775:Photic Stimulation; D010911:Pituitary Neoplasms / Q000150:complications*